Filing Flows

Filing Flows › Esab (ESAB) › Q2 2026 › vs Q1 2026

Esab (ESAB) Q2 2026 vs Q1 2026 (quarter over quarter)

Esab's revenue rose $62.0M (+8%) from $746M in Q1 2026 to $808M in Q2 2026. The biggest changes: Equipment +$48.3M (+18%); Consumables +$13.7M (+3%). Gross margin 38.0% against 36.9% (+1.1 pts).

Esab, Q2 2026: revenue $808M (+13% year over year), operating margin 9.7%, net earnings $32.4M, operating cash flow $33.4M. The chart draws each line against Q1 2026, the increases inside each band.

Esab: what changed, Q2 2026 vs Q1 2026Esab: what changed, Q2 2026 vs Q1 2026Equipment$48.3MOperating expenses$43.9MGross profit$32.1MCost of revenue$29.9MFree cash flow (OCF − capex)−$17.5MPre-tax earnings−$16.7MNet earnings−$15.3MConsumables$13.7MOperating cash flow−$13.5MOperating profit−$11.8M

Margins

Q2 2026Q1 2026Change
Gross margin38.0%36.9%+1.1 pts
Operating margin9.7%12.1%-2.4 pts
Net margin4.0%6.4%-2.4 pts
Free cash flow margin1.9%4.5%-2.5 pts

Every line

LineQ2 2026Q1 2026Change%
Consumables$495M$481M$13.7M+3%
Equipment$313M$265M$48.3M+18%
Revenue$808M$746M$62.0M+8%
Gross profit$307M$275M$32.1M+12%
Cost of revenue$500M$470M$29.9M+6%
Operating profit$78.7M$90.5M−$11.8M-13%
Operating expenses$228M$185M$43.9M+24%
Pre-tax earnings$45.7M$62.3M−$16.7M-27%
Other expense, net$33.0M$28.1M$4.9M+17%
Net earnings$32.4M$47.6M−$15.3M-32%
Minority interests$1.6M$1.6M$41K+3%
Income tax$11.7M$13.1M−$1.4M-11%
Operating cash sources$66.7M$75.5M−$8.8M-12%
Depreciation & amortization$27.9M$23.9M$4.0M+17%
Share-based compensation$6.4M$3.9M$2.5M+63%
Working capital & other$33.2M$28.5M$4.7M+16%
Operating cash flow$33.4M$46.9M−$13.5M-29%
Free cash flow (OCF − capex)$15.7M$33.2M−$17.5M-53%
Capital expenditures$17.7M$13.7M$4.0M+29%

Questions

How much did Esab's revenue grow quarter over quarter in Q2 2026?

Esab's revenue rose $62.0M (+8%) from $746M in Q1 2026 to $808M in Q2 2026.

What drove Esab's revenue change in Q2 2026?

Equipment +$48.3M (+18%); Consumables +$13.7M (+3%).

Q2 2026 results → · Compare in the interactive Sankey →